Une Afrique en meilleure santé et plus riche

ZURICH – Les pays des BRIC (Brésil, Russie, Inde et Chine) ont longtemps été le centre d’attention principal des investisseurs dans les marchés émergents. Mais c'est en Afrique, une région qui connait la seconde croissance la plus rapide au monde, que les prochaines grandes opportunités de faire des affaires se trouvent désormais. Dans environ un tiers des 55 pays du continent, la croissance annuelle du PIB dépasse 6% et l'Afrique sub-saharienne a crû à un rythme estimé à 5,1% en 2013.

Les investisseurs étrangers rapportent que leur retour sur investissement en Afrique est plus élevé que dans toute autre région émergente. On estime qu’en 2040, la population en âge de travailler sur le continent totalisera 1,1 milliard de personnes, fournissant aux entreprises un bassin de main-d'œuvre plus grand que même celui de la Chine ou de l'Inde. En outre, l'expansion économique ne se déroule pas seulement dans les centres urbains, mais également dans les petites villes et villages.

Cependant, l'Afrique est également confrontée à des défis majeurs. Une des plus grandes préoccupations sont les soins de santé inadéquats. La population est infestée de maladies évitables et traitables. L'espérance de vie est de 14 ans inférieure à la moyenne mondiale. Près d'un adulte sur 20 dans le groupe d'âge 15-49 ans en Afrique sub-saharienne vit avec le VIH – environ six fois la moyenne mondiale. Chaque minute, un enfant africain meurt du paludisme.

To continue reading, please log in or enter your email address.

Registration is quick and easy and requires only your email address. If you already have an account with us, please log in. Or subscribe now for unlimited access.

required

Log in

http://prosyn.org/JXPBpV7/fr;
  1. Chris J Ratcliffe/Getty Images

    The Brexit Surrender

    European Union leaders meeting in Brussels have given the go-ahead to talks with Britain on post-Brexit trade relations. But, as European Council President Donald Tusk has said, the most difficult challenge – forging a workable deal that secures broad political support on both sides – still lies ahead.

  2. The Great US Tax Debate

    ROBERT J. BARRO vs. JASON FURMAN & LAWRENCE H. SUMMERS on the impact of the GOP tax  overhaul.


    • Congressional Republicans are finalizing a tax-reform package that will reshape the business environment by lowering the corporate-tax rate and overhauling deductions. 

    • But will the plan's far-reaching changes provide the boost to investment and growth that its backers promise?


    ROBERT J. BARRO | How US Corporate Tax Reform Will Boost Growth

    JASON FURMAN & LAWRENCE H. SUMMERS | Robert Barro's Tax Reform Advocacy: A Response

  3. Murdoch's Last Stand?

    Rupert Murdoch’s sale of 21st Century Fox’s entertainment assets to Disney for $66 billion may mark the end of the media mogul’s career, which will long be remembered for its corrosive effect on democratic discourse on both sides of the Atlantic. 

    From enabling the rise of Donald Trump to hacking the telephone of a murdered British schoolgirl, Murdoch’s media empire has staked its success on stoking populist rage.

  4. Bank of England Leon Neal/Getty Images

    The Dangerous Delusion of Price Stability

    Since the hyperinflation of the 1970s, which central banks were right to combat by whatever means necessary, maintaining positive but low inflation has become a monetary-policy obsession. But, because the world economy has changed dramatically since then, central bankers have started to miss the monetary-policy forest for the trees.

  5. Harvard’s Jeffrey Frankel Measures the GOP’s Tax Plan

    Jeffrey Frankel, a professor at Harvard University’s Kennedy School of Government and a former member of President Bill Clinton’s Council of Economic Advisers, outlines the five criteria he uses to judge the efficacy of tax reform efforts. And in his view, the US Republicans’ most recent offering fails miserably.

  6. A box containing viles of human embryonic Stem Cell cultures Sandy Huffaker/Getty Images

    The Holy Grail of Genetic Engineering

    CRISPR-Cas – a gene-editing technique that is far more precise and efficient than any that has come before it – is poised to change the world. But ensuring that those changes are positive – helping to fight tumors and mosquito-borne illnesses, for example – will require scientists to apply the utmost caution.

  7. The Year Ahead 2018

    The world’s leading thinkers and policymakers examine what’s come apart in the past year, and anticipate what will define the year ahead.

    Order now